Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WEST PHARMACEUTICAL SERVICES INC Director's Dealing 2013

Aug 9, 2013

30339_dirs_2013-08-09_5ed0ffd7-8b1c-4d20-8cee-815a9af76eae.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-08-08

Reporting Person: ANDERSON MICHAEL A (Vice President & Treasurer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-08-08 Common Stock M 3000.0000 $25.5300 Acquired 48602.8320 Direct
2013-08-08 Common Stock S 1300.0000 $78.0000 Disposed 47302.8320 Direct
2013-08-08 Common Stock S 3000.0000 $78.0000 Disposed 44302.8320 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-08-08 Stock Option (Right to Buy) $25.5300 M 3000.0000 Disposed 2015-03-09 Common Stock (3000.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 448.9269 Indirect
Common Stock 4243.6554 Indirect

Footnotes

F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.